BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 479604)

  • 21. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
    J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of long-term cultures of proliferating, mononuclear phagocytes from bone marrow.
    van der Meer JW; van de Gevel JS; van Furth R
    J Reticuloendothel Soc; 1983 Sep; 34(3):203-25. PubMed ID: 6620253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter.
    Tam MR; Emmons SL; Pollack SB
    J Immunol; 1980 Feb; 124(2):650-5. PubMed ID: 6985934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cells generated from bone marrow culture.
    Koo GC; Peppard JR; Mark WH
    J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression.
    Hurwitz JL; McAndrew EC; Doherty PC
    J Immunol; 1986 Sep; 137(6):1757-63. PubMed ID: 2875109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.
    van Kessel KP; Visser MR; van Strijp JA; van Kats-Renaud JH; Verhoef J
    Immunology; 1986 Jun; 58(2):291-6. PubMed ID: 3710525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of human natural killer cells against target cells possessing different sensitivity to interferon].
    Cheknev SB; Narovlianskiĭ AN; Amchenkova AM; Sorokin AM; Khesin IaE; Ershov FI
    Biull Eksp Biol Med; 1990 Oct; 110(10):406-9. PubMed ID: 1703793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of natural killer cell lines from murine long-term bone marrow cultures.
    Yung YP; Okumura K; Moore MA
    J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Macrophage precursors as cytotoxic effector cells (author's transl)].
    Lohmann-Matthes ML; Zähringer M
    Blut; 1981 May; 42(5):283-95. PubMed ID: 7236895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.